Takeda Pharmaceutical Company Limited (TAK) Reports Q3 EPS of JPY279.00
Takeda Pharmaceutical Company Limited (NYSE: TAK) reported Q3 EPS of JPY279.00. Revenue for the quarter came in at JPY2219.5 billion.
For earnings history and earnings-related data on Takeda Pharmaceutical Company Limited (TAK) click here.
